(Q64112374)

English

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group

scientific article published on 01 October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

endometrial carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Pawinski

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Tumolo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Hoesel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Cervantes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A T van Oosterom

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G H Boes

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Pecorelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

European Journal of Obstetrics Gynecology and Reproductive Biology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

86

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

179-183

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of ifosfamide in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II studies of ifosfamide alone and in combination in cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900066-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-2115(99)00066-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10509788%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64112374&oldid=2131014672"